Inventiva Pharma
Annick Schwebig has served as a member of the Board of Directors since February 2017. Mrs. Schwebig was the founder and Chief Executive Officer of Actelion Pharmaceuticals France from 2000 to 2015, a laboratory specializing in the development of drugs for orphan diseases. She has held senior positions in the pharmaceutical industry as Vice-President of Medical Affairs France and Vice-President of Research and Development Europe at Bristol-Myers Squibb from 1983 to 2000.
Mrs. Schwebig has been a member of the Board of Directors of Cellectis since 2011. She is a graduate of the Faculty of Medicine of Paris.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Inventiva Pharma
Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology.